CN101843726B - Chinese medicament for treating chronic hepatitis - Google Patents
Chinese medicament for treating chronic hepatitis Download PDFInfo
- Publication number
- CN101843726B CN101843726B CN2009102361944A CN200910236194A CN101843726B CN 101843726 B CN101843726 B CN 101843726B CN 2009102361944 A CN2009102361944 A CN 2009102361944A CN 200910236194 A CN200910236194 A CN 200910236194A CN 101843726 B CN101843726 B CN 101843726B
- Authority
- CN
- China
- Prior art keywords
- chinese
- chinese medicine
- parts
- chronic hepatitis
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 206010008909 Chronic Hepatitis Diseases 0.000 title claims abstract description 12
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 208000010643 digestive system disease Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010019668 Hepatic fibrosis Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese medicament for treating chronic hepatitis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: wild chrysanthemum, radix pseudo-ginseng, Chinese angelica, dandelion, lucid ganoderma, root of rehmannia, Chinese magnoliavine fruit and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, clearing heat and detoxicating, and tonifying qi and nourishing liver, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function descend, hepatic fibrosis is serious etc., patient's life quality descends, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Flos Chrysanthemi Indici 4-30 part Radix Notoginseng 3-20 part Radix Angelicae Sinensis 5-40 part
Herba Taraxaci 4-30 part Ganoderma 2-15 part Radix Rehmanniae 4-30 part
Fructus Schisandrae Chinensis 3-25 part
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Flos Chrysanthemi Indici, Radix Angelicae Sinensis, Herba Taraxaci, the Radix Rehmanniae, Fructus Schisandrae Chinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side; Be fated return, the pseudo-ginseng blood-circulation-invigovating blood stasis dispelling, the effective enhancing human body immunity power of last four flavors, the prosperous hemapodium of gas, liver function protecting; Herba Taraxaci, Flos Chrysanthemi Indici antiviral removing heat from the liver, heat-clearing and toxic substances removing; The Fructus Schisandrae Chinensis profit kidney of astringing the lung, mind tranquilizing and the heart calming, QI invigorating nourishing the liver.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, the merit of QI invigorating nourishing the liver, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Flos Chrysanthemi Indici 55 gram Radix Notoginseng 40 gram Radix Angelicae Sinensis 55 grams
The Herba Taraxaci 55 kairine sesames 30 gram Radix Rehmanniae 55 grams
Fructus Schisandrae Chinensis 40 grams
Weight in accordance with regulations, with conventional water extraction process Flos Chrysanthemi Indici, Radix Angelicae Sinensis, Herba Taraxaci, the Radix Rehmanniae, Fructus Schisandrae Chinensis are extracted, make extractum fine powder 78 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 529 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Flos Chrysanthemi Indici 180 gram Radix Notoginseng 120 gram Radix Angelicae Sinensis 15 grams
The Herba Taraxaci 180 kairine sesames 90 gram Radix Rehmanniae 150 grams
Fructus Schisandrae Chinensis 120 grams
By above-mentioned same method, make 1586 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Flos Chrysanthemi Indici 300 gram Radix Notoginseng 200 gram Radix Angelicae Sinensis 300 grams
The Herba Taraxaci 300 kairine sesames 150 gram Radix Rehmanniae 300 grams
Fructus Schisandrae Chinensis 250 grams
By above-mentioned same method, make 2804 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5 parts of 4 parts of Radix Angelicae Sinensis of 5 portions of Radix Notoginseng of Flos Chrysanthemi Indici
5 parts in 3 parts of Radix Rehmanniae of 5 portions of Ganodermas of Herba Taraxaci
4 parts of Fructus Schisandrae Chinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 18 parts of Radix Angelicae Sinensis of 20 portions of Radix Notoginseng of Flos Chrysanthemi Indici
25 parts in 12 parts of Radix Rehmanniae of 20 portions of Ganodermas of Herba Taraxaci
15 parts of Fructus Schisandrae Chinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 14 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are defective.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 7 examples, women's 7 examples do not have other serious disease, and the age is 47 years old-78 years old, 61.3 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is alleviated obviously; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.14 philtrums of clinical experiment, produce effects 5 people, effective 8 people, invalid 1 people, total effective rate 92.8%.
Claims (1)
1. a Chinese medicine for the treatment of chronic hepatitis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Flos Chrysanthemi Indici 4---40 parts of 30 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 5---
Herba Taraxaci 4---30 parts of 30 portions of Ganodermas 2---15 parts of Radix Rehmanniae 4---
Fructus Schisandrae Chinensis 3---25 parts;
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Flos Chrysanthemi Indici, Radix Angelicae Sinensis, Herba Taraxaci, the Radix Rehmanniae, Fructus Schisandrae Chinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102361944A CN101843726B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102361944A CN101843726B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843726A CN101843726A (en) | 2010-09-29 |
| CN101843726B true CN101843726B (en) | 2011-08-17 |
Family
ID=42768663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102361944A Expired - Fee Related CN101843726B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843726B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110236055A (en) * | 2019-07-29 | 2019-09-17 | 卢珊玲 | A kind of pectase beverage of protect liver and preparation method thereof |
-
2009
- 2009-10-22 CN CN2009102361944A patent/CN101843726B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843726A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843789B (en) | Chinese medicament for treating gout | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843704B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843709B (en) | Chinese medicament for treating abnormal menstruation | |
| CN101850046B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843817B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843877B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101874870B (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843777B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843729B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843866A (en) | Chinese medicament for treating diabetic feet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU XINZHUANG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150722 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150722 Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102 Patentee after: Liu Xinzhuang Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110817 |